Cannabix (TSE:BLO) has released an update.
Cannabix Technologies Inc., a leader in the development of marijuana and alcohol breath testing devices, is excited to announce the appointment of Dr. Phillip Olla to its board of directors. Dr. Olla brings a wealth of experience, having conducted pioneering research in breath analysis and worked with major companies such as IBM and Roche Diagnostics. His expertise is expected to propel Cannabix’s breathalyzer technologies forward in the U.S. and European markets while exploring new applications and commercial opportunities.
For further insights into TSE:BLO stock, check out TipRanks’ Stock Analysis page.
